NCT03478514 2026-04-09Phase II Palbociclib +Ibrutinib in Mantle Cell LymphomaAlliance Foundation Trials, LLC.Phase 2 Active not recruiting39 enrolled
NCT01111188 2019-06-27Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell LymphomaWeill Medical College of Cornell UniversityPhase 1 Terminated20 enrolled